August 01, 2017
Cleveland – The National Center for Excellence in Fighting Blindness, a Gund-Harrington Initiative, has opened its fourth annual Gund-Harrington Scholar Award competition to support innovative research efforts that seek to prevent, treat or cure blindness.
The Gund-Harrington Initiative is a collaboration between Foundation Fighting Blindness (FFB) and the Harrington Discovery Institute at University Hospitals in Cleveland, Ohio – part of The Harrington Project for Discovery & Development.
In addition to funding, award recipients receive drug development and project management support through the Harrington Discovery Institute’s Innovation Support Center for the duration of the term of the award. This includes hands-on industry guidance from experienced pharmaceutical development professionals, as well as regulatory, intellectual property and business development assistance not found in traditional academic research settings.
This award is open to PhD and MD researchers at accredited academic medical centers, research institutions and universities in the United States and Canada. Multidisciplinary discovery with potential application to the eye is being sought, as are investigators studying fundamental processes with multidisciplinary applications and rare inherited retinal diseases.
Gund-Harrington Scholars will receive:
Gund-Harrington Scholars also have facilitated access to BioMotiv – part of The Harrington Project for Discovery & Development – a for-profit commercialization company that is aligned with the Harrington Discovery Institute in mission and structure. BioMotiv was created to further advance discoveries by academic researchers in areas of unmet need.
Letters of Intent are accepted through October 25, 2017.